Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 14;13(1):60.
doi: 10.3390/toxins13010060.

A Neurotoxic Snake Venom without Phospholipase A2: Proteomics and Cross-Neutralization of the Venom from Senegalese Cobra, Naja senegalensis (Subgenus: Uraeus)

Affiliations

A Neurotoxic Snake Venom without Phospholipase A2: Proteomics and Cross-Neutralization of the Venom from Senegalese Cobra, Naja senegalensis (Subgenus: Uraeus)

Kin Ying Wong et al. Toxins (Basel). .

Abstract

The Senegalese cobra, Naja senegalensis, is a non-spitting cobra species newly erected from the Naja haje complex. Naja senegalensis causes neurotoxic envenomation in Western Africa but its venom properties remain underexplored. Applying a protein decomplexation proteomic approach, this study unveiled the unique complexity of the venom composition. Three-finger toxins constituted the major component, accounting for 75.91% of total venom proteins. Of these, cardiotoxin/cytotoxin (~53%) and alpha-neurotoxins (~23%) predominated in the venom proteome. Phospholipase A2, however, was not present in the venom, suggesting a unique snake venom phenotype found in this species. The venom, despite the absence of PLA2, is highly lethal with an intravenous LD50 of 0.39 µg/g in mice, consistent with the high abundance of alpha-neurotoxins (predominating long neurotoxins) in the venom. The hetero-specific VINS African Polyvalent Antivenom (VAPAV) was immunoreactive to the venom, implying conserved protein antigenicity in the venoms of N. senegalensis and N. haje. Furthermore, VAPAV was able to cross-neutralize the lethal effect of N. senegalensis venom but the potency was limited (0.59 mg venom completely neutralized per mL antivenom, or ~82 LD50 per ml of antivenom). The efficacy of antivenom should be further improved to optimize the treatment of cobra bite envenomation in Africa.

Keywords: Naja (Uraeus) senegalensis; Naja haje complex; antivenom neutralization; immunoreactivity; snakebite envenomation; venomics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Geographical distribution of Naja senegalensis in Western Africa, encompassing Senegal, Gambia, Mali, Burkino Faso, Ghana, Benin, Guinea-Bissau, Nigeria, and the Ivory Coast (yellow region) [5]. Insets: Naja senegalensis from the subgenus of Uraeus, elevated as a new species from the Naja haje complex. Note the distinct hood marking which is uncommon in African but Asiatic cobras. Snake photograph was courtesy of Laurent Chirio with copyright © Magnelia Press 2009 [12].
Figure 2
Figure 2
Reverse-phase high-performance liquid chromatography of Naja senegalensis venom. Chromatogram of the venom fractionation (top panel) and separation of venom fractions using SDS-PAGE under reducing condition (bottom panel). M, protein ladder for estimating the molecular weight of sample proteins.
Figure 3
Figure 3
Snake venom proteome of Naja senegalensis. Proteomic profiling was accomplished with QTOF nano-ESI-LCMS/MS of reverse-phase HPLC-fractionated venom proteins. All protein samples were subjected to in-solution tryptic digestion. Abbreviations: CTX, cytotoxin/cardiotoxin; SNTX, short neurotoxin; LNTX, long neurotoxin; WTX, weak neurotoxin; CRISP, cysteine-rich secretory protein; CVF, cobra venom factor; KSPI, Kunitz-type serine protease inhibitor; PDE, phosphodiesterase; SVMP, snake venom metalloproteinase; 5′-NUC, 5′-nucleotidase. CTX, SNTX, LNTX, and WTX constituted three-finger toxins (3FTX) superfamily.
Figure 4
Figure 4
Immunological binding activity of VINS African Polyvalent Antivenom (VAPAV) toward N. senegalensis and N. haje venoms. The immunological binding activity was represented as half the maximum concentration (EC50). Values were means ± S.E.M. of triplicates.

Similar articles

Cited by

References

    1. Gutiérrez J.M., Calvete J.J., Habib A.G., Harrison R.A., Williams D.J., Warrell D.A. Snakebite envenoming. Nat. Rev. Dis. Primers. 2017;3:17063. doi: 10.1038/nrdp.2017.63. - DOI - PubMed
    1. Harrison R.A., Hargreaves A., Wagstaff S.C., Faragher B., Lalloo D.G. Snake envenoming: A disease of poverty. PLoS Negl. Trop. Dis. 2009;3:e569. doi: 10.1371/journal.pntd.0000569. - DOI - PMC - PubMed
    1. Chippaux J.-P. Snakebite envenomation turns again into a neglected tropical disease! J. Venom. Anim. Toxins Incl. Trop. Dis. 2017;23:38. doi: 10.1186/s40409-017-0127-6. - DOI - PMC - PubMed
    1. Williams D.J., Faiz M.A., Abela-Ridder B., Ainsworth S., Bulfone T.C., Nickerson A.D., Habib A.G., Junghanss T., Fan H.W., Turner M., et al. Strategy for a globally coordinated response to a priority neglected tropical disease: Snakebite envenoming. PLoS Negl. Trop. Dis. 2019;13:e0007059. doi: 10.1371/journal.pntd.0007059. - DOI - PMC - PubMed
    1. WHO Venomous Snakes and Antivenoms Search Interface. [(accessed on 2 April 2020)]; Available online: http://apps.who.int/bloodproducts/snakeantivenoms/database/

Publication types

LinkOut - more resources